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The Nur transcription factors Nur77 (NGFI-B, NR4A1), Nurr1 (NR4A2), and Nor-1 (NR4A3)
are a sub-family of orphan members of the nuclear receptor superfamily. These
transcription factors are products of immediate early genes, whose expression is rapidly
and transiently induced in the central nervous system by several types of stimuli. Nur
factors are present throughout the hypothalamus-pituitary-adrenal (HPA) axis where are
prominently induced in response to stress. Drugs of abuse and stress also induce the
expression of Nur factors in nuclei of the motivation/reward circuit of the brain, indicating
their participation in the process of drug addiction and in non-hypothalamic responses
to stress. Repeated use of addictive drugs and chronic stress induce long-lasting
dysregulation of the brain motivation/reward circuit due to reprogramming of gene
expression and enduring alterations in neuronal function. Here, we review the data
supporting that Nur transcription factors are key players in the molecular basis of the
dysregulation of neuronal circuits involved in chronic stress and addiction.
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INTRODUCTION
The transcription factors Nur77 (NGFI-B, NR4A1) (Hazel et al.,
1988; Milbrandt, 1988), Nurr1 (NR4A2) (Law et al., 1992) and
Nor-1 (NR4A3) (Ohkura et al., 1996) are orphan members of
the nuclear receptor superfamily and together conform the Nur
subfamily. Nur transcription factors, as members of the nuclear
receptor superfamily, share their classic structural organiza-
tion (Figure 1A) encompassing: (a) a non-conserved N-terminal
region containing the transcriptional activation function-1 (AF-
1), (b) a conserved DNA binding domain (DBD) located in the
middle of the proteins, with 90.2% of amino acid sequence iden-
tity among all rat Nur factors, and (c) a moderately conserved
C-terminal domain, which encloses the ligand-binding domain
(LBD) and the ligand-dependent transcriptional activation func-
tion 2 or AF-2 (Giguere, 1999). Although Nur transcription fac-
tors have a well-recognized LBD structure, their transcriptional
activity is not regulated by endogenous ligands as it is for steroid
nuclear receptors (Benoit et al., 2004). Crystallographic studies
show that the putative ligand-binding pocket of Nurr1 and Nur77
LBDs are filled with side chains of large hydrophobic amino
acids, which keep the LBD in a transcriptionally active confor-
mation (Wang et al., 2003; Flaig et al., 2005). Since the binding
of ligands does not trigger the transcriptional activity of Nur
factors, changes of their expression levels and post-translational
modifications appear keys to regulate their activity.
Nur factors behave as immediate early genes, and as such, their
mRNA expression is induced independent of protein synthesis
in several cell types by multiple kinds of stimuli (Williams
and Lau, 1993; Maruyama et al., 1995; Satoh and Kuroda,
2002; Maxwell and Muscat, 2006). Nur factors show some basal
expression in specific nuclei of the rodent brain (Zetterstrom
et al., 1996b). However, remarkable fast and high induction has
been observed for Nur factors in selected brain nuclei or disso-
ciated neurons after physiological, chemical or toxic stimulation
(Chan et al., 1993; Honkaniemi et al., 1994; Jacobs et al., 1994;
Umemoto et al., 1994; Svenningsson et al., 1995; Imaki et al.,
1996; Svenningsson and Fredholm, 1997; Tang et al., 1997; Xing
et al., 1997; Honkaniemi and Sharp, 1999; Brosenitsch and Katz,
2001; Ojeda et al., 2003; Maheux et al., 2005). These data strongly
support the notion that Nur factors have homeostatic functions
and, functioning as immediate-early gene, can also serve as rapid
signaling system.
To exert their function as transcriptional regulators, Nur fac-
tors bind to nerve-growth-factor inducible gene B (NGFI-B)-
responsive element (NBRE) (A/TAAAGGTCA) (Wilson et al.,
1991) as monomers (Figure 1B) (Wilson et al., 1993a; Paulsen
et al., 1995), and to Nur-responsive element (NurRE) (inverted
repeated of NBRE-related octanucleotide, AAATG/AC/TCA)
(Philips et al., 1997) as homodimers or heterodimers between
Nur factors (Philips et al., 1997; Maira et al., 1999). Nur77 and
Nurr1, but not Nor-1, can also form heterodimers with RXR
retinoid receptor (Perlmann and Jansson, 1995; Zetterstrom et al.,
1996a). These heterodimers activate transcription through NBRE
elements, where the Nur component binds to the NBRE element,
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FIGURE 1 | Scheme of Nur factors structure and DNA-binding
elements. (A) Nur factors common structure, AF: activation function
domain; DBD: DNA Binding Domain; LBD: Ligand Binding Domain. (B) Nur
factors DNA binding elements. RXR: retinoic-X-receptor; 9-cis RA: 9-cis
retinoic acid.
or through DR5 elements (two direct repeats of the consen-
sus nuclear receptor binding motif separated by five nucleotides,
GGTTCAnnnnnAGGTCA). In the case of DR5 elements, both
nuclear receptors bind to the DNA (Perlmann and Jansson,
1995). In addition, Nur factors can regulate transcription indi-
rectly by binding to another transcription factor. For instance,
Nurr1 represses transcription of inflammatory genes in microglia
indirectly by forming a complex with NF-kB transcription factor
(Saijo et al., 2009).
Increasing reports show that Nur factors transcriptional activ-
ity is regulated by post-translational modifications (Figure 2).
Phosphorylation of Nur77 by extracellular-signal regulated
kinase 2 (ERK2) is required for its transcriptional activity in
corticotrophs (Kovalovsky et al., 2002). Similarly, Nurr1 phos-
phorylation by mitogenic-activated protein kinases increases its
transcriptional activity (Nordzell et al., 2004; Sacchetti et al.,
2006; Zhang et al., 2007). Phosphorylation of Nur factors plays
an important role also in their subcellular translocation and Nur-
dependent induction of apoptosis (Katagiri et al., 2000; Slagsvold
et al., 2002; Wingate et al., 2006). The post-translational modi-
fication SUMOylation has appeared as an important regulatory
pathway of Nurr1 transcriptional activity (Galleguillos et al.,
2004; Saijo et al., 2009; Arredondo et al., 2013). All Nur fac-
tors harbor SUMO consensus motifs in their sequences, but
only Nurr1 SUMOylation by SUMO2 and SUMO3 has been
FIGURE 2 | Nur factors are post-translational modified. (A)
Phosphorylation, (B) SUMOylation, and (C) Acetylation and ubiquitination.
demonstrated. SUMOylation of the N-terminal domain of Nurr1
with SUMO2 reduces its transcriptional activity in promoters
harboring more than one NBRE element (Arredondo et al.,
2013). Also, SUMOylation with SUMO2 or SUMO3 of the C-
terminal of Nurr1 is required to bind the corepressor CoREST
and repress pro-inflammatory gene expression (Saijo et al., 2009).
Recent work has shown that Nur factors turnover and transcrip-
tional activity are regulated by acetylation (Kang et al., 2010) and
ubiquitination (van Tiel et al., 2012; Alvarez-Castelao et al., 2013).
Nur factors are associated to several functions (Maxwell and
Muscat, 2006). Some of the functions are exclusive of one factor,
like the essential role of Nurr1 in the induction and mainte-
nance of midbrain dopamine neurons (Zetterstrom et al., 1997;
Castillo et al., 1998; Saucedo-Cardenas et al., 1998; Kadkhodaei
et al., 2009), and Nor-1 requirement for normal embryonic devel-
opment (Deyoung et al., 2003), inner ear (Ponnio et al., 2002),
and hippocampus development (Ponnio and Conneely, 2004).
Increasing evidence indicates that all Nur factors play significant
roles in inflammatory (McMorrow and Murphy, 2011; van Tiel
and de Vries, 2012) and oncogenic processes (Mohan et al., 2012).
Increased expression levels of Nur factors have been observed in
several types of cancer cell lines and tumors, although the oppo-
site has also been reported. Collected data suggest that Nur77
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behaves as a pro-oncogenic factor (Lee et al., 2011). However,
the double knockout of Nur77 and Nor-1 induced a fatal acute
myeloid leukemia in mice (Mullican et al., 2007), indicating that
these nuclear receptors may also play a role as tumor suppres-
sors (Mullican et al., 2007). The apparent controversy or dual role
of Nur factors as tumor suppressors and/or pro-oncogenic fac-
tors could be explained by a dual role in transcription, behaving
as transcriptional activators or repressors. Since Nur factors are
transcriptionally active in their native form, less attention has
been paid to their role as potential transcriptional repressors.
Interestingly, there are several reports showing the interaction
of Nur factors with transcriptional corepressors. For example,
we showed that PIASγ interacts and represses Nurr1-dependent
transcriptional activity (Galleguillos et al., 2004). Nurr1 also
interacts with the transcriptional repressors SMRT (Lammi et al.,
2008; Jacobs et al., 2009) and CoREST (Saijo et al., 2009). The
interaction with SMRT maintains Nurr1 in a transcriptional
repressive complex impeding the induction of its dopaminergic
target genes (Jacobs et al., 2009). It has also been shown the inter-
action between Nur77 and SMRT (Sohn et al., 2001). Regarding
the role of Nur77 and Nor-1 repressing the expression of target
genes, it was shown that abrogation of these transcription fac-
tors correlates with an increased expression of MYC oncogene
(Boudreaux et al., 2012). In addition, it was demonstrated that
MYC is a direct target gene of Nur77/Nor-1, whose expression
was strongly repressed in a Nur DNA-binding dependent way
(Boudreaux et al., 2012). Nur77 and Nor-1 play also an important
role triggering apoptosis in several cell types. Interestingly, this
effect is due to the translocation of Nur77/Nor-1 from the nuclei
to the mitochondria, where Nur77 triggers cytochrome c release
and apoptosis (Li et al., 2000). Through this mechanism, Nur77
and Nor-1 play a central function in the clonal deletion of autore-
active thymocytes (Sohn et al., 2007). Nur77 and Nor-1 colocalize
in several cell types, including CNS neurons, and apparently
they replace each other in some functions. This colocalization of
Nur77 and Nor-1 explain the lack of deleterious effects in the
single knockout mice, while lack of both induces a catastrophic
deregulation in the immune system. Similarly, colocalization of
Nur77 with Nor-1 in the CNS may explain an apparent lack of
strong effect of each knockout in the stress and rewarding systems
of the brain.
Nur TRANSCRIPTION FACTORS AND DOPAMINERGIC
TRANSMISSION
Histological and neurochemical evidence supports the idea that
Nur transcription factors are closely associated with dopamine
neurotransmission (Figure 3, Table 1). Nur77 and Nor-1 are
expressed in neurons of the striatum, the nucleus accumbens
(NAc) and the prefrontal cortex (PFC) (Xiao et al., 1996;
Zetterstrom et al., 1996b; Gervais et al., 1999; Werme et al.,
2000a,b; Davis and Puhl, 2011), all target nuclei of dopaminer-
gic neurons originated in the ventral midbrain. In these nuclei,
a strong control of Nur77 and Nor-1 expression is induced by
the stimulation of the dopamine neurons (Chergui et al., 1997);
by the administration of dopamine D2 receptor agonists and
antagonists (Gervais et al., 1999; Beaudry et al., 2000; Werme
et al., 2000b; Langlois et al., 2001; Maheux et al., 2005); by
FIGURE 3 | Expression of Nur factors in the in the motivation/reward
circuit. Nurr1 is expressed in dopamine neurons of the SN/VTA and Nur77
and Nor-1 are expressed in dopamine-receptive GABAergic neurons of the
striatum/NAc. GABAergic projecting neurons in the striatum/NAc are
segregated in two populations that express either D1 or D2 receptors
(Valjent et al., 2009).
drugs of abuse (Werme et al., 2000a; St-Hilaire et al., 2003b)
and after dopamine denervation. Collected data indicate that
Nur77 expression is under a tonic inhibitory control exerted by
physiological dopamine basal levels through D2 receptor. Acute
administration of dopamine D2 agonists decreases Nur77 mRNA
levels in the striatum (Gervais et al., 1999), while the opposite
is observed after acute dopamine D2 antagonist administration
in the striatum, NAc and PFC (Beaudry et al., 2000; Langlois
et al., 2001; Maheux et al., 2005). Interestingly, D2 antagonist-
dependent induction of Nur77 expression in the striatum and
NAc core is preserved after chronic treatment with D2 ligands
(Beaudry et al., 2000; Werme et al., 2000b; Mahmoudi et al.,
2009, 2013), suggesting that this transcription factor mediates
adaptive changes to long-term repetitive dopamine variations
(Levesque and Rouillard, 2007).
Studies using dopamine denervation and Nur77 knockout
mice have been instrumental to reveal the role of Nur77 as a
master factor for adaptations induced by dopaminergic neu-
rotransmission changes. Full lesion of dopamine nigro-striatal
pathway and D2 antagonist administration produce a signifi-
cant up-regulation of both Nur77 and enkephalin mRNA in
enkephalin positive neurons of the striatum (Beaudry et al.,
2000; St-Hilaire et al., 2003a, 2005). Enkephalin up-regulation
induced byD2 antagonists or by dopamine denervation is severely
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Table 1 | Nur transcription factors and dopaminergic neurotransmission.
Nur factor Expression Effect of DA agonists, antagonists, KO characteristics
psychostimulants, and 6-OHDA
Nur77 High: Striatum, NAc, PFC,
olfactory bulb and tubercle,
cortex, hippocampal formation,
hypothalamus and amygdalaa−e
Low: VTA, SNa−e
D1 agonist:
D2 agonist:
D2 antagonist:
Psychostimulants:
(amphetamine, cocaine,
and others)
D1 and D2 agonists:
6-OHDA in striatum:
No effects in striatumf, g
mRNA down- regulated in
striatumf, g
mRNA up-regulated in striatum,
PFC,
NAc, VTA, and SNc, h, i, j, p
mRNA up-regulated in striatum
and NAce, k, l
mRNA up-regulated in striatumf
mRNA up-regulated in striatumf
L-DOPA treatment: complex
regulation in striatumf
D2R increases in dorsal
striatumm, n
Alterations in the expression of
NT and ENKm, o
Increased locomotor activityn
Increased sensitivity to low dose
of D2 agonistn
Increased DOPAC in SN and VTAn
Decreased cataleptic response
after D2R antagonistm
Decreased COMT expressionn
Nor-1 High: Striatum, NAc, PFC,
olfactory bulb and tubercle,
cortex, hippocampal formation,
hypothalamus and amygdalaa−e
Low: VTA, SNa−e
D2 Antagonist:
Psychostimulants:
(amphetamine, cocaine
and others)
mRNA up-regulated in striatum,
NAc, PFC, VTA and SNh, p
mRNA up-regulated in NAc,
striatum and cortexe, l
Not viable embryos. Embryos die
at early stagesq
Nurr1 High: VTA, SNa, b
Low: cortex, hippocampal
formation, olfactory bulb,
hypothalamusa, b
Psychostimulants in drug
abusers: (amphetamine,
cocaine and others)
6-OHDA in striatum:
mRNA down-regulated in SN and
VTAq, r
mRNA up-regulated in SNs
Agenesis DA neuronst
DA: dopamine; 6-OHDA: 6-hydroxydopamine; L-DOPA: 3,4-dihydroxyphenylalanine; DOPAC: dihydroxyphenylacetic acid; COMT: catechol-O-methyltransferase; ENK:
enkephalin; NT: neurotensin.
aGofflot et al., 2007
bZetterstrom et al., 1996a,b
cBeaudry et al., 2000
dPonnio and Conneely, 2004
eWerme et al., 2000a,b
f St-Hilaire et al., 2003a
gGervais et al., 1999
hMaheux et al., 2005
iLanglois et al., 2001
jMaheux et al., 2012
kSt-Hilaire et al., 2003b
lKrasnova et al., 2011
mEthier et al., 2004
nGilbert et al., 2006
oSt-Hilaire et al., 2006
pMaheux et al., 2012
qNielsen et al., 2008
rHorvath et al., 2007
sOjeda et al., 2003
tZetterstrom et al., 1997; Castillo et al., 1998; Saucedo-Cardenas et al., 1998.
impaired in Nur77 knockout mice (Ethier et al., 2004; St-Hilaire
et al., 2006). Moreover, the normalization of enkephalin levels
induced by L-DOPA treatment of dopamine denervated ani-
mals is not observed in Nur77 knockout mice (St-Hilaire et al.,
2006), indicating that Nur77 is essential for this adaptive effect.
Interestingly, a recent publication suggests that the D2 control
over Nur77 expression in the striatum is due to presynaptic
D2 receptors located on glutamatergic terminals coming from
the cortex (Maheux et al., 2012). Metabotropic mGlu5 recep-
tor antagonist suppressed D2 antagonist-induced Nur77 expres-
sion (Maheux et al., 2012), indicating that glutamate positively
controls Nur77 expression in the striatum. These data show that
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Nur77 may play an integrative role of multiple signaling in the
striatum.
mRNA levels of Nur77 and Nor-1 are extremely low or
absent in adult midbrain dopaminergic neurons of substantia
nigra (SN) and ventral tegmental area (VTA) in basal condi-
tions (Zetterstrom et al., 1996a,b). However, current data indicate
that Nur77 may play an important role regulating dopamine bio-
chemical homeostasis in these nuclei. Nur77-deficient mice show
an increase in dopamine D2 receptors in dorsolateral striatum;
enhanced spontaneous locomotor activity; greater sensitivity to
dopamine D2 receptor agonists and higher levels of DOPAC rela-
tive to the wild-type (Gilbert et al., 2006). Remarkably, Nur77 and
Nor-1 expression increases significantly in midbrain dopamine
neurons after the administration of dopamine D2 receptor antag-
onists (Maheux et al., 2005).
Unlike Nur77 and Nor-1, Nurr1 is expressed under basal
physiological conditions in dopamine neurons of SN and VTA
(Xiao et al., 1996; Zetterstrom et al., 1996a; Backman et al.,
1999; Ojeda et al., 2003). Strong evidence indicates that Nurr1
is essential for the development of these neurons (Zetterstrom
et al., 1997; Castillo et al., 1998; Saucedo-Cardenas et al., 1998).
More recently, it was shown that Nurr1 is also critical to main-
tain midbrain dopamine neurons in the adult (Kadkhodaei
et al., 2009). During development, dopamine midbrain precur-
sors do not differentiate into dopaminergic phenotype in the
Nurr1 null mice (Zetterstrom et al., 1997; Castillo et al., 1998;
Saucedo-Cardenas et al., 1998). Dopaminergic markers like tyro-
sine hydroxylase (TH), the dopamine transporter (DAT), the
vesicular monoamine transporter (VMAT2) and the tyrosine
kinase receptor RET (Wallen et al., 2001) are not expressed in
the ventral mesencephalon of Nurr1 null mice at birth (reviewed
in Smidt et al., 2003; Perlmann and Wallen-Mackenzie, 2004).
On the other hand, a progressive decline in the expression of
the same genes in the SN and VTA is observed when Nurr1 is
ablated in adults (Kadkhodaei et al., 2009, 2013; Galleguillos et al.,
2010). Interestingly, it was recently shown that Nurr1 regulates
the expression of a set of mitochondria genes (Kadkhodaei et al.,
2013). Whether, the role of Nurr1 keeping dopamine neuron fully
functional during adulthood and aging is related to the control of
genes of the phenotype or mitochondrial genes or both requires
further evidence.
The accumulated evidence indicate that Nurr1 regulates the
transcription of dopamine phenotype genes (Sakurada et al.,
1999; Iwawaki et al., 2000; Sacchetti et al., 2001; Hermanson
et al., 2003; Kim et al., 2003; Smits et al., 2003; Galleguillos
et al., 2010). Studies in Nurr1-deficient mice (±) indicate that
the amount of Nurr1 is important to keep homeostasis during
the life of dopamine neurons (Le et al., 1999; Jiang et al., 2005;
Eells et al., 2006; Zhang et al., 2012). For instance, aged Nurr1
(±) mice have a significant decrease in rotarod performance and
locomotor activity, a motor impairment analogous to Parkinson’s
disease associated with decreased dopamine levels in the stria-
tum (Jiang et al., 2005). Recently, it was shown that a decreased
number of TH positive cells in SN, observed in aged Nurr1 (±)
mice, correlates with decreased dopamine release in the striatum
(Zhang et al., 2012). Similarly, we showed that inducing a 50%
decrease of Nurr1 expression in the SN of adult rats results in a
significant decrease of dopamine extracellular levels in the stria-
tum associated with decreased expression of the tyrosine kinase
receptor RET (Galleguillos et al., 2010). Nurr1-deficient mice
(±) also show some symptoms related to schizophrenia, such
as hyperactivity in a novel environment, deficiency in the reten-
tion of emotional memory and increased response to swim stress;
all symptoms associated with dysfunctions in dopamine neuro-
transmission (Rojas et al., 2007; Vuillermot et al., 2011). Thus,
these data show that Nurr1 controls the expression of dopamine
phenotype genes during adulthood. In addition, the data show
that survival pathways, which are stressed during aging, require a
stronger Nurr1 signaling, that cannot be achieved in Nurr1 het-
erozygous mice. Remarkably, the amount of Nurr1 protein levels
seems to play a significant role controlling the expression of spe-
cific sets of target genes. Indeed, the group of Bannon (Johnson
et al., 2011), showed that different set of genes are controlled by
lower vs. higher Nurr1 level.
How Nurr1 is regulated by dopamine levels and adjusts
the expression of target genes accordingly? Accumulated data
indicates that Nurr1 expression depends on dopamine signaling,
mainly through D2 receptors. D2 receptors are located in soma
and dendrites, to regulate firing rate of neurons and presy-
naptically in axons to regulate dopamine synthesis and release.
Drugs of abuse like cocaine decrease Nurr1 in mesencephalon
(Bannon et al., 2002, 2004). D2 receptor knockout mice have
increased Nurr1 expression in midbrain dopamine neurons
(Tseng et al., 2000) and the loss of dopamine in rat striatum
induced by 6-hydroxydopamine generates a rapid increase
of Nurr1 expression in dopamine neurons of the SN (Ojeda
et al., 2003). These data show that dopamine extracellular levels
influence the expression of Nurr1 in the SN and VTA. Recent
evidence indicates that neuronal firing regulates differentially the
expression of Nurr1 and Nur77 in dopamine neurons (Eells et al.,
2012). A normal flow of impulses maintains basal expression
of Nurr1. Surprisingly, Nur77 was induced with a lower D2
autoreceptor activation in the VTA (Eells et al., 2012). Recently,
it was shown that D2 receptors located postsynaptically in GABA
projecting neurons of the striatum also regulate dopamine release
(Anzalone et al., 2012). Nurr1 and/or Nur77 could be the targets
of such a feedback mechanism regulating dopamine home-
ostasis. The recent findings of Nur77 controlling dopaminergic
homeostasis raises several questions regarding the specific role
of each Nur factor in dopaminergic gene expression: Are Nur
factors redundant or they play particular roles in the adaptation
and survival processes of midbrain dopamine neurons during
adulthood and aging?
Nur TRANSCRIPTION FACTORS DURING THE STRESS
RESPONSE
In response to stressful stimuli, secretory neurons of the paraven-
tricular nucleus (PVN) discharge corticotropin-releasing factor
(CRF) that in turn increases both the secretion of adrenocor-
ticotrophin hormone (ACTH) and the transcription of its pre-
cursor, the proopiomelanocortin (POMC) gene, in the anterior
pituitary. ACTH stimulates the release of glucocorticoids (GCs)
and the transcription of genes encoding several steroidogenic
enzymes in the adrenal gland. GCs exert diverse effects on target
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tissues to mobilize energy for the body to deal with the stres-
sor, and also exert a negative feedback through the inhibition
of the synthesis and secretion of CRF and POMC (Keller-Wood
andDallman, 1984; Sawchenko and Swanson, 1985; Antoni, 1986;
Swanson and Simmons, 1989).
Several lines of evidence indicate that Nur transcription factors
play a prominent role in adaptive responses to stress, regulating
the transcription of target genes in the hypothalamus-pituitary-
adrenal (HPA) axis (Figure 4). The evidence indicates that this
nuclear receptor subfamily regulates the expression of CRF and
POMC in the PVN and pituitary, respectively (Murphy and
Conneely, 1997; Drouin et al., 1998). In the adrenal glands, Nur77
and Nor-1 also regulate the expression of steroid-21α-hydroxylase
and 3-β-hydroxysteroid dehydrogenase, both enzymes essential
for the production of GCs (Figure 4) (Wilson et al., 1993b;
Fernandez et al., 2000; Bassett et al., 2004).
A complex signaling cascade involving Nur factors is required
for POMC regulation. The group of Eduardo Arzt (Kovalovsky
et al., 2002) showed that in AtT-20 corticotrophs, CRF induces
both Nur77 and Nurr1 expression resulting in POMC transcrip-
tion through a NurRE site in its promoter. While CRF-mediated
induction of Nur factors requires protein kinase A (PKA) and
FIGURE 4 | Scheme of Nur factors expression in the HPA axis.
cAMP signaling, POMC transcriptional induction depends fur-
ther on MAPK activation. Nur77-dependent induction of POMC
transcription required the phosphorylation of Nur77 by MAPK
(Kovalovsky et al., 2002). Concordantly, cAMP/PKA signal-
ing enhances DNA binding activity of Nur dimers, but not
monomers, and the recruitment of transcriptional coactivators
through the AF-1 domain of Nur factors (Maira et al., 2003). Nur
transcription factors are also involved in the ending of the stress
response. The effect of Nur transcription factors on POMC pro-
moter is antagonized by GCs (Philips et al., 1997; Drouin et al.,
1998; Martens et al., 2005; Carpentier et al., 2008). The NurRE
element of the POMC gene, which binds Nur dimers, is the tar-
get of the repressive effect of GCs. GC receptors bound to ligands
directly interact with Nur factors inducing the transrepression of
POMC (Martens et al., 2005).
Less is known about the role of Nur factors regulating CRF
in the PVN. While Nurr1 is expressed constitutively in the PVN
(Saucedo-Cardenas and Conneely, 1996), Nur77 is transiently
induced by different types of stressful stimuli (Chan et al., 1993;
Honkaniemi et al., 1994; Imaki et al., 1996; Kawasaki et al.,
2005), and by central administration of CRF (Parkes et al., 1993).
Interestingly, an increased expression of Nur77 occurs in the PVN
of virgin and lactating females, but not in pregnant mice stressed
either by exposure to a novel environment or forced swimming
(Douglas et al., 2003), suggesting a role for sex hormones regulat-
ing Nur factors action. In 1997, Murphy and Conneely showed
that Nurr1 and Nur77 bind and transactivate the CRF gene
(Murphy and Conneely, 1997). The CRF gene promoter harbors
a conserved NBRE element (Murphy et al., 1996; Yao and Denver,
2007; Yao et al., 2007), which is required for Nur77-dependent
inductive effect of reporters driven by the CRF promoter (Murphy
and Conneely, 1997). More recently, Stroth et al. (2011) showed
that up-regulation of mRNAs encoding CRF and Nur factors in
the PVN during stress depends on Pituitary Adenylate Cyclase
Activating Polypeptide (PACAP). Indeed, not only CRF, but also
restraint-induced expression of Nur77 and Nurr1 decreases in
the pituitary gland of PACAP-deficient mice (Stroth et al., 2011),
suggesting a reciprocal regulation between Nur factors and CRF.
Normal function of the HPA axis in Nur77 null mutant mice
indicates redundancy of Nur factors. Nurr1 mRNA increases in
the adrenal gland of Nur77 null mice (Crawford et al., 1995). In
addition, Nor-1 and Nur77 play similar, albeit distinct roles in
the HPA axis. Similar to Nur77, Nor-1 activates the expression of
the gene encoding steroid-21α-hydroxylase (Wilson et al., 1993b;
Fernandez et al., 2000) throughNBRE elements. In contrast, DNA
binding experiments of Nor-1 to NurRE element suggest that
Nor-1 is not an efficient substitute of Nur77 activation of POMC
gene expression in the pituitary gland (Fernandez et al., 2000).
In addition to its crucial role in the activation of the HPA axis,
CRF functions as a neurotransmitter/neuromodulator coordinat-
ing extra-hypothalamic aspects of the stress response (Aguilera,
1998; Ziegler and Herman, 2000; Herman et al., 2002). The
extra-hypothalamic aspects of the stress response are mediated
by interconnected nuclei of the amygdala and the bed nucleus
of the stria terminalis (BNST) (Walker et al., 2003). The BNST
is the primary integrative center of excitatory and inhibitory
inputs regulating the HPA axis during stress (Forray and Gysling,
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2004), and mediates anxiety-like behavior resulting of extended
threat (Walker et al., 2009). The expression of Nur transcription
factors increases in the limbic nuclei associated to the extra-
hypothalamic aspects of the stress response, suggesting that Nur
factors could also underlie enduring changes induced by chronic
stress. For instance, Nor-1 is increased in the somatosensory cor-
tex and amygdala when exposed to novelty stress (Sun et al.,
2007). Predator stress increases Nur77mRNA in prelimbic, infral-
imbic and, ventral and lateral orbital prefrontal cortexes (Schiltz
et al., 2007). Nurr1 expression increases while TH decreases at
postnatal day 7 in the VTA of prenatally stressed offspring, which
suggest a possible compensatory mechanism that may play Nurr1
to counteract the observed reduction of dopamine levels (Katunar
et al., 2009, 2010). In addition, dopamine content decreases
within the PFC and midbrain of rats subjected to forced swim
test, meanwhile Nurr1 expression increases in the same brain
areas (Rojas et al., 2010) supporting a role for Nurr1 counter-
acting the decrease of dopamine content. Intriguingly, Eells et al.
(2002) showed that Nurr1 (±) mice displayed significantly greater
locomotor activity in response to mild stress that correlated with
lower dopamine content in mesolimbic and mesocortical circuits
(Eells et al., 2002). Taken together the data indicate that Nur fac-
tors expression is modulated in limbic circuit during the response
to stress. It is unknown what are the genes induced or repressed
by Nur factors in the nuclei associated to the extra-hypothalamic
aspects of the stress response. One possible target is CRF.
Repeated immobilization stress and chronic mild stress induce
CRF expression in the BNST (Stout et al., 2000; Santibanez et al.,
2006). We reported that cells expressing CRF in the BNST also
express Nur77 (Campos-Melo et al., 2011), even though the
expression of Nur77 is wider than CRF in this nucleus. Nur77
expression increases significantly in the dorso-lateral and ventro-
medial subdivisions of the BNST after acute and repeated immo-
bilization stress (Campos-Melo et al., 2011), same areas where
CRF expression increases after repeated immobilization stress
(Santibanez et al., 2006). Several years ago, it was shown that the
intracerebroventricular injection of CRF increases CRF expres-
sion in the PVN (Parkes et al., 1993). A CRF-dependent induction
of CRF could be a mechanism of maintaining CRF expression
in brain nuclei associated to chronic stress-induced anxiety and
depression (Stenzel-Poore et al., 1994; Pelton et al., 1997; Yao and
Denver, 2007). In support of this suggestion (Parkes et al., 1993),
immunohistochemical data show that CRF neurons are inner-
vated by CRF axons in PVN and amygdala (Moga et al., 1989;
Silverman et al., 1989; Moga and Saper, 1994). Similarly, in BNST,
positive CRF terminals also innervate CRF neurons (Sakanaka
et al., 1986; Veinante et al., 1997). Since CRF induces the expres-
sion of Nur77 (Kovalovsky et al., 2002) and Nur77 also is able to
induce CRF expression (Murphy and Conneely, 1997), it is possi-
ble that Nur77 could mediate the vicious cycle of CRF-dependent
CRF induction in the PVN and limbic nuclei, during chronic
stress; an hypothesis that requires further investigation.
FUNCTIONAL ROLE OF Nur TRANSCRIPTION FACTORS IN
THE ADDICTION PROCESS. PROTECTORS OR INSTIGATORS?
The motivation/reward circuit has its roots in dopamine neurons
located in the VTA, which send afferences to the NAc, BNST,
septum, amygdala, and PFC. Acute administration of drugs of
abuse, which increase dopamine release (Di Chiara and Imperato,
1988), induce the expression of Nur77 and Nor-1 in nuclei of
the motivation/reward circuit (Table 1) (Werme et al., 2000a;
St-Hilaire et al., 2003b; Krasnova et al., 2011). Nur77 and
Nor-1 are up-regulated in the NAc, striatum, and cortex after
acute administration of cocaine and morphine (Werme et al.,
2000a). Similarly, acute administration of methamphetamine up-
regulates the expression of Nur77 in cortex, striatum and NAc
core; and of Nurr1 in the cortex and VTA. Pretreatment with
a selective antagonist of D1/D5 dopamine receptors prevents
methamphetamine-induced expression of both Nur77 and Nurr1
mRNA, supporting that dopamine-mediated signaling regulates
Nur transcription factors expression (Akiyama et al., 2008). In
concordance, the simultaneous administration of D1 and D2 ago-
nists increases Nur77 expression in the striatum (St-Hilaire et al.,
2003b). However, D1 agonists administered alone do not mod-
ify Nur77 expression in the striatum (St-Hilaire et al., 2003a).
As analyzed before, substantial data indicate that dopamine D2
antagonists increase, while D2 agonists decrease Nur77 and Nor-
1 expression in the striatum (Beaudry et al., 2000; Werme et al.,
2000a,b; Langlois et al., 2001;Maheux et al., 2005, 2012; St-Hilaire
et al., 2005). How could this paradox be explained? Taken together
the available evidence suggests that drugs of abuse would require
another neurotransmitter system, besides dopamine, in order
to induce Nur77 in GABA projecting neurons of the striatum.
Nur77 induction by D2 antagonists in GABA projecting neu-
rons depends on glutamate signaling through mGlu5 receptors
(Maheux et al., 2012). Maheux et al. (2012) showed that ablation
of the long isoform of dopamine D2 receptors, located post-
synaptically do not prevent D2 antagonists-dependent induction
of Nur77, indicating that the effect is presynaptic, where the short
isoform of the D2 receptor is present. Presynaptic D2 recep-
tors are located in dopaminergic and glutamatergic axons in the
striatum. This result was further supported by showing that inter-
rupting glutamate neurotransmission to the striatum by cortex
lesion prevented the increase of Nur77 expression induced by
D2 antagonists (Maheux et al., 2012). It is tempting to suggest
that similarly, drugs of abuse-dependent induction of Nur77 in
the striatum and NAc depends, besides dopamine, on glutamate
neurotransmission. Dopamine- and glutamate-dependent induc-
tion of Nur77 supports a role for Nur77 integrating pre and
postsynaptic information in striatal GABA projecting neurons.
The development of compulsive running, associated with a
high risk of addictive behavior, correlates with lower Nur77 and
Nor1 expression in several nuclei of the motivation/reward cir-
cuit, in the addiction-prone Lewis rat strain compared with the
less-addiction prone Fisher rats which do not develop com-
pulsive running (Werme et al., 1999). Accordingly, Nur77 null
mice show increased locomotor activity, but a similar locomo-
tor sensitization than wild type mice after repeated amphetamine
administration (Bourhis et al., 2009). Interestingly, the block-
ade of amphetamine-induced locomotor sensitization by an RXR
antagonist is abolished in Nur77 null mice (Bourhis et al.,
2009). Together the data suggest that Nur77 regulates addiction-
prone phenotype and sensitization by different mechanisms. The
available information regarding Nurr1 protecting or facilitating
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addictive behaviors is unclear. In one study it was shown that
Nurr1 (±) mice do not develop compulsive running behavior and
high ethanol consumption compared to wild type mice (Werme
et al., 2003). In another study it was shown that Nurr1 (±)
mice have an increased basal locomotor activity and augmented
locomotor response to acute methamphetamine administration
(Backman et al., 2003). Mice genetic background, behavioral
protocols, among other parameters, may influence these observa-
tions. Remarkably, in a recent work it was shown that ablation of
the histone deacetylase HDAC3 in the NAc facilitates condition-
place preference induced by cocaine (Rogge et al., 2013). This
effect was correlated with increased Nurr1 expression in this
nucleus, supporting a role for Nurr1 facilitating addiction behav-
iors (Rogge et al., 2013).
It has been proposed that the persistent behavioral and cog-
nitive effects of chronic intake of drugs of abuse depend on
new programs of gene expression triggered by immediate-early
genes. Tolerance and sensitization of Nur factors expression in
nuclei of the motivation/reward and stress brain circuits sug-
gest that these early genes play a signaling role in the plastic
changes underlying long-term adaptations. Studies in cocaine
abusers showed a reduction of Nurr1 expression in SN neu-
rons (Nielsen et al., 2008). This decreased expression of Nurr1
correlates with a reduction of DAT expression in the same neu-
rons (Bannon et al., 2002). Similarly, rats chronically treated
with cocaine show a down-regulation of the expression of Nurr1
mRNA and protein in the ventral midbrain (Leo et al., 2007).
Additionally, chronic use of heroin decreases Nurr1 mRNA
to a greater extent with age in the paranigral nucleus of the
VTA (Horvath et al., 2007). Nurr1 expression decreases after
chronic intake of drugs of abuse, could be an adaptive change
to excessive dopamine stimulation, and also could be indica-
tive of Nurr1 role adjusting the expression of dopamine tar-
get genes during the addiction process. In this regard, it was
shown that an acute methamphetamine challenge to animals
pretreated with methamphetamine causes a further decrease in
Nurr1 mRNA levels (McCoy et al., 2011), indicating that the
signaling system regulating Nurr1 expression adapts to new
parameters.
Opposing to a tolerance effect observed for Nurr1; Nur77
seems to adapt to dopamine changes and its levels are still
inducible after chronic drug intake. For instance, it has been
shown that Nur77 expression increases in the frontal cortex of
rats after 10 days of cocaine self-administration (Freeman et al.,
2002b) or 14 days in a binge model of cocaine administration
(Freeman et al., 2002a), and in the dorsal striatum after 7 days
of cocaine self-administration (Lynch et al., 2008). On other
hand, it was shown that the expression of several early-genes,
including Nur factors, is no longer induced in the striatum after
chronic exposure to methamphetamine (McCoy et al., 2011). It
is noteworthy that Nor-1 is still significantly induced in the stria-
tum of methamphetamine chronically-treated rats, indicating the
capacity of the system to respond in new settings.
Chronic stress also triggers tolerance and sensitization of Nur
factors expression. In the PVN, it has been shown that Nur77 is no
longer induced after chronic stress stimuli (Umemoto et al., 1994,
1997). In contrast, in the ventral region of the BNST, we observed
a higher number of cells expressing Nur77 after repeated immo-
bilization stress compared with acute stress (Campos-Melo et al.,
2011). Interestingly, the data of the group of Marta Antonelli
(Katunar et al., 2010) suggest that Nurr1 may be the transcrip-
tion factor setting up the new parameters of the dopamine system
after prenatal stress. Using prenatal restraint stress, they showed
that Nurr1 is permanently higher in the VTA, but not in the SN,
in the offspring of stressed mothers. This increment of Nurr1
expression in the VTA correlates with several changes in the moti-
vation/reward dopamine system that persist to adulthood (Baier
et al., 2012). An exciting work indicates that Nur factors integrate
stress and drug addiction signaling. Postweaning isolation causes
elevation in amphetamine-induced dopamine overflow in Nurr1
(−/+) mice, but a reduction in (+/+) mice (Moore et al., 2008).
These data demonstrate that a deletion of a single allele of Nurr1,
which produced only subtle phenotypic changes, when coupled
with a developmental stressor such as postweaning isolation, can
dramatically alter mesoaccumbens dopamine neurotransmission
(Moore et al., 2008).
CONCLUSIONS
Chronic stress plays a primary role in the origin of several
brain pathologies such as anxiety and depression (McCormick
and Green, 2013), and facilitates and perpetuates drug addic-
tion (Koob, 2008; Sinha, 2008). Chronic stress and repeated use
of addictive drugs induce long-lasting alterations of the moti-
vation/reward circuit and HPA axis (Koob and Le Moal, 2001).
The evidence presented points to Nur transcription factors as
orchestrators of the molecular bases of the reorganization of these
circuits under stressful stimuli and exposure to addictive drugs,
since their expression is fast, transient and strongly regulated
by dopamine, glutamate, and CRF in the nuclei of the motiva-
tion/reward circuit and HPA axis. The features of Nur factors
as early genes and orphan nuclear receptors allow them to inte-
grate and transmit fast responses to incoming neurotransmitter
signals in neurons. The transient nature of the changes in Nur
factor levels suggest that they can re-program the expression of
target genes in response to acute and chronic dopamine changes
by adjusting their inducibility to the new conditions, as occur-
ring during chronic stress or after repeated exposure to drugs
of abuse. Finally, the localization of Nurr1 in dopamine neurons
andNur77/Nor-1 in dopamine-receptive neurons, positions them
to translate the dopaminergic information simultaneously to the
genome of pre and post-synaptic neurons, allowing an integra-
tive signaling of the motivation/reward circuit. Identifying the
intracellular signaling pathways inducing Nur factors expression
and their target genes is essential to elucidate their function in
normal physiology as well as in addiction and anxiety disorders.
These findings might offer novel targets to treat these devastating
conditions.
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